ÂÜÀòÂÒÂ×

Greg Fischer is currently the VP Finance at Kula Bio. Prior to this, they were the Interim Head of Finance at Arranta Bio from August 2020 to May 2022. In this role, they were responsible for leading the FP&A and Accounting functions.

Before Arranta Bio, Greg was at MilliporeSigma from April 2015 to December 2016 as the Associate Director - Operations Controlling. In this role, they were responsible for Global Operations Support, Global Operations Reporting, Forecasting, & Consolidations, Global Quality & Regulatory - Controlling representative to the Quality Leadership Team, and Global Capital Expenditures Reporting & Facilitation.

In May 2013, Greg had a temporary assignment as the Plant Controller at Merck Millipore.

From December 2016 to July 2020, Greg was the Director of Finance - Global Strategic Accounts & Americas Region at MilliporeSigma. In this role, they managed a team of Finance Business Partners responsible for supporting the 15 Global Strategic Accounts and the Americas Region within the Process Solutions Business Unit of MilliporeSigma. Greg was also responsible for long and short term Sales Planning / Forecasting (FP&A) as well as supporting negotiations with large customers (Revenue Forecasting / Payment Terms / Freight Considerations / Overall Business Case Modelling).

Greg Fischer attended Boston College Carroll School of Management, where they earned their Master of Business Administration (MBA). Greg also studied finance at Northeastern University and Avon Old Farms.

Their manager is Bill Brady, CEO & Director. Some of their coworkers include Harrison Yoon - COO, Frederic Kendirgi - VP, Manufacturing, and Jon Sammons - VP, Sales, Marketing & Agronomy.